Y Combinator is a startup accelerator that invests in a large number of startups twice a year. It created a new model for funding startups. Twice a year, the company invests a small amount of money ($150k) in a large number of startups. The startup accelerator works intensively with the companies for three months, to get them into the best possible shape and refine their pitch to investors. Each cycle culminates in Demo Day when the startups present their companies to a carefully selected, invite-only audience.

Y Combinator

SeedToB Capital primarily focuses on artificial intelligence initiatives within healthcare. Most applications of AI in healthcare have results in pilot and early adaptor settings but don’t maximize their full potential of value despite huge investments. seedToB’s unique approach is to help entrepreneurs navigate this complex space towards most efficient path to Series B. It is led by serial entrepreneurs who in their last startup founded Jvion and grew it to be the Nation’s largest clinical AI company which was sold at nine figure valuation in a all cash transaction.

SeedToB Capital

DigiLife is a healthcare technology company that specializes in Healthcare IT, web, and mobile applications.

DigiLife

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital to date.  The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Gaingels

Tamar Capital (TC) integrates risk management, cash management, asset management, and financial planning. The company is quite active and has large interests in a number of industries, including FMCG, manufacturing, and real estate. It is present throughout the Middle East, the GCC, the UK, and the US. It also maintains a diverse portfolio of assets and enterprises, making use of the family office's expertise where appropriate to generate long-term value. It is also becoming more involved in impact investment.

Tamar Capital

Axial VC

North South Ventures is a cross-border venture capital fund that invests in early stage med companies. We are co-located in academic med superclusters (Stanford/UCSF and University of Toronto).  As a team, we have invested in over 350 medical portfolio companies and 40+ FDA approvals in the biotech, med device, and digital health/AI spaces with $4B+ in cumulative funding and three multi billion dollar IPOs since 2012.

North South Ventures

Founded in 2020, Citta Capital is a venture capital based in Palo Alto, California. The firm prefers to invest in early stage and early growth stage companies.  The firm seeks to invest in artificial intelligence/machine learning, big data, cloud, healthcare technology, IoT, marketplaces, SaaS and enterprise, security, blockchain, and robotics.

Citta Capital

At Founders, Inc. we're quietly building the next gen. of emerging tech companies. We start companies from scratch through our venture Studio: - thirdweb ($30M raised)  - buildspace ($10M raised)  - Zeet ($4M raised)  - Scenario ($6M raised)  And we bet on early-stage builders - sometimes even before they're ready to start a company (past investments include Lexica, Levels.fyi, and more). Are you a prolific builder with an affinity for emerging tech? We'll be your first check.

Founders, Inc.

Zeit Medical

Zeit Medical provides therapy for neurological injuries by identifying signature patterns in EEG and enables physicians to diagnose and treat with precision.  The company was founded in 20202019 by Urs Naber and Orestis Vardoulis.

Zeit develops an early stroke detection system for patients during sleep. The headband device includes an electroencephalogram (EEG) that is connected to the company’s mobile app. The system analyzes brain activity and leverages machine learning to identify signs of an impending stroke. If any anomalies are detected, an alarm is sent to the user and pre-specified caregivers. It can also be set to call 911 automatically.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Zeit

Zeit Medical raises $2 million

<div>
 
 California-based Zeit develops an early stroke detection system for patients during sleep. The headband device includes an electroencephalogram (EEG) that is connected to the company&rsquo;s mobile app. The system analyzes brain activity and leverages machine learning to identify signs of an impending stroke. If any anomalies are detected, an alarm is sent to the user and pre-specified caregivers. It can also be set to call 911 automatically. The device is yet to be commercialized and the company is planning for a commercial launch in 2023. 
 
 
 In October 2021, the company raised USD 2 million in a seed funding round just after leaving the seed accelerator company, Y Combinator&rsquo;s Summer 2021 program. The funding round was co-led by SeedToB Capital and DigiLife, with participation from Y Combinator, and was allocated towards expanding its operations and scaling its team. The company had also planned to invest in two prerequisite studies for the approval of its stroke detection wearable from the FDA.
 
</div>

Zeit develops an early stroke detection system for patients during sleep. The headband device includes an electroencephalogram (EEG) that is connected to the company’s mobile app. The system analyzes brain activity and leverages machine learning to identify signs of an impending stroke. If any anomalies are detected, an alarm is sent to the user and pre-specified caregivers. It can also be set to call 911 automatically.As of May 2024, the device has a FDA breakthrough device designation and is yet to be commercialized.Funding and financialsIn October 2021, the company raised USD 2 million in a seed funding round just after leaving the seed accelerator company, Y Combinator’s Summer 2021 program. The funding round was co-led by SeedToB Capital and DigiLife and was used to expand its operations and scale its team.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

Zeit

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless